Pulmonary Or Respiratory Drug Delivery Global Market Report 2025
상품코드:1815876
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
폐 또는 호흡기 약물 전달 시장 규모는 향후 몇 년 동안 강력한 성장이 예상됩니다. 2029년에 연평균 성장률(CAGR)은 8.6%를 나타낼 것으로 예측되고 1,053억 2,000만 달러로 성장할 전망입니다. 예측 기간 동안의 성장은 맞춤형 의약품에 대한 수요 증가, 만성 호흡기 질환 유병률 상승, 원격의료에 대한 강조 증가, 의료 인프라 투자 확대, 의약품 전자상거래 성장 등에 기인할 수 있습니다. 예측 기간의 주요 트렌드로는 입자 공학 발전, 첨단 분무기 개발, 리포솜 제형 개발, 전산 유체 역학 발전, 스마트 흡입기 개발 등이 포함됩니다.
향후 5년간 8.6% 성장 전망은 해당 시장에 대한 이전 추정치 대비 0.4% 소폭 하향 조정된 수치입니다. 이 같은 하향 조정은 주로 미국과 타국 간 관세 영향 때문입니다. 관세 장벽은 스웨덴 및 일본에서 조달되는 진동 메쉬 분무기와 스마트 흡입기 기술의 비용을 증가시켜 미국 병원들의 치료 효율성을 저하시키고 호흡기 치료 장치 비용을 상승시킬 것으로 예상됩니다. 상호 보복 관세와 무역 긴장 및 제한 강화로 인한 세계 경제 및 무역에 대한 부정적 영향으로 그 효과는 더욱 광범위하게 나타날 것입니다.
폐렴 발생률 증가는 폐 또는 호흡기 약물 전달 시장의 성장을 주도할 것으로 예상됩니다. 폐렴은 폐포에 염증을 일으키는 폐 감염으로, 폐포가 체액이나 고름으로 가득 차 기침, 발열, 호흡 곤란 등의 증상을 유발할 수 있습니다. 폐렴 유병률 증가 요인으로는 고령화 인구, 면역 체계 약화, 호흡기 감염, 대기 오염, 흡연, 항생제 내성균 확산 등이 있습니다. 폐 또는 호흡기 약물 전달은 항생제, 기관지 확장제, 항염증제 등의 약물을 폐에 직접 전달하여 폐렴 치료를 돕습니다. 이를 통해 증상 완화, 염증 감소, 감염 제거, 호흡 기능 개선을 위한 신속하고 효과적인 치료가 가능해져 회복을 촉진하고 합병증을 예방합니다. 예를 들어, 2023년 11월 열대 의학 및 글로벌 보건 센터는 케냐에서 폐렴 사례가 크게 증가하여 2022-2023년의 기간 동안 79만 3,864건에 달했다고 보고했습니다. 이처럼 폐렴 유병률의 증가는 폐 또는 호흡기 약물 전달 시장의 성장을 주도하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 폐 또는 호흡기 약물 전달 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인 및 억제요인)
최종 이용 산업의 분석
세계의 폐 또는 호흡기 약물 전달 시장 : 성장률 분석
세계의 폐 또는 호흡기 약물 전달 시장 실적 : 규모와 성장(2019-2024년)
세계의 폐 또는 호흡기 약물 전달 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 폐 또는 호흡기 약물 전달 : 총 잠재시장 규모(TAM)
제6장 시장 세분화
세계의 폐 또는 호흡기 약물 전달 시장 : 제품별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
처방 유형
장치 유형
세계의 폐 또는 호흡기 약물전달 시장 : 캐니스터 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
일반 캐니스터
코팅 캐니스터
세계의 폐 또는 호흡기 약물 전달 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
만성 폐쇄성 폐질환(COPD)
천식
낭포성 섬유증
기타 용도
세계의 폐 또는 호흡기 약물 전달 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병원
클리닉
재택 케어 설정
세계의 폐 또는 호흡기 약물 전달 시장, 처방 유형별 세분화 : 분석과 예측(2019-2024년, 2024-2029년, 2034년)
건식 분말 흡입기(DPI)
계량 흡입기(MDI)
네뷸라이저
액체 에어로졸
비강 스프레이
세계의 폐 또는 호흡기 약물 전달 시장, 장치 유형별 세분화 : 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
흡입기(수동식 및 디지털식)
네뷸라이저(압축식, 초음파식, 메쉬식)
호흡 작동 장치
스페이서 장치
비강 약물 약물 전달 장치
제7장 지역별, 국가별 분석
세계의 폐 또는 호흡기 약물 전달 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 폐 또는 호흡기 약물 전달 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
폐 또는 호흡기 약물 전달 시장 : 경쟁 구도
폐 또는 호흡기 약물 전달 시장 : 기업 프로파일
Merck & Co. Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Novartis AG : 개요, 제품 및 서비스, 전략 및 재무 분석
Thermo Fisher Scientific Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
AstraZeneca plc : 개요, 제품 및 서비스, 전략 및 재무 분석
Abbott Laboratories : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
3M Company
Koninklijke Philips NV
GlaxoSmithKline
Omron Corporation
Teva Pharmaceutical Industries Ltd.
Aptar Pharma
Sumitomo Pharma America Inc.
Chiesi Farmaceutici SpA
Cipla Inc.
Boehringer Ingelheim GmbH
Kindeva Drug Delivery Limited
Nemera Group
Hovione
H And T Presspart Group
Vectura Group plc
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
폐 또는 호흡기 약물 전달 시장(2029년) : 새로운 기회를 제공하는 국가
폐 또는 호흡기 약물 전달 시장(2029년) : 새로운 기회를 제공하는 부문
폐 또는 호흡기 약물 전달 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
HBR
영문 목차
영문목차
Pulmonary or respiratory drug delivery involves the direct administration of medication into the lungs to facilitate quick absorption, targeted treatment, and minimize systemic side effects, offering both local and systemic therapeutic benefits.
The primary categories of pulmonary or respiratory drug delivery include formulation type and device type. Formulation type pertains to the method of preparing drugs for efficient delivery, ensuring precise dosing and absorption in the body. Different canister options include plain and coated canisters, which are utilized for treating conditions such as chronic obstructive pulmonary disease, asthma, cystic fibrosis, and others. These devices are commonly used across various settings, including hospitals, clinics, and home care environments.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the pharmaceutical sector. Companies are grappling with higher costs on imported active pharmaceutical ingredients (APIs), glass vials, and laboratory equipment-many of which have limited alternative sources. Generic drug manufacturers, already operating with minimal profit margins, are particularly affected, with some scaling back production of low-margin medications. Biotech firms are also experiencing delays in clinical trials due to shortages of specialized reagents linked to tariffs. In response, the industry is shifting API production to regions like India and Europe, building up inventory reserves, and advocating for tariff exemptions on essential medicines.
The pulmonary or respiratory drug delivery market research report is one of a series of new reports from The Business Research Company that provides pulmonary or respiratory drug delivery market statistics, including pulmonary or respiratory drug delivery industry global market size, regional shares, competitors with a pulmonary or respiratory drug delivery market share, detailed pulmonary or respiratory drug delivery market segments, market trends and opportunities, and any further data you may need to thrive in the pulmonary or respiratory drug delivery industry. This pulmonary or respiratory drug delivery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The pulmonary or respiratory drug delivery market size has grown strongly in recent years. It will grow from $69.83 billion in 2024 to $75.67 billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to increasing prevalence of asthma, rising adoption of advanced inhalation devices, growth in healthcare expenditure globally, rising awareness of respiratory diseases, and rising incidence of allergic conditions.
The pulmonary or respiratory drug delivery market size is expected to see strong growth in the next few years. It will grow to $105.32 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to rising demand for personalized medicine, rising prevalence of chronic respiratory diseases, growing emphasis on telemedicine, increasing investments in healthcare infrastructure, and growth in e-commerce for pharmaceutical products. Major trends in the forecast period include advancements in particle engineering, development of advanced nebulizers, development of liposomal formulations, advancements in computational fluid dynamics, development of smart inhalers.
The forecast of 8.6% growth over the next five years reflects a modest reduction of 0.4% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper U.S. hospitals by increasing the cost of vibrating mesh nebulizers and smart inhaler technologies sourced from Sweden and Japan, thereby reducing treatment efficacy and elevating respiratory therapy equipment costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The rising incidence of pneumonia is expected to drive the growth of the pulmonary or respiratory drug delivery market. Pneumonia is a lung infection that causes inflammation in the air sacs, which may fill with fluid or pus, resulting in symptoms such as cough, fever, and difficulty breathing. Factors contributing to the increasing prevalence of pneumonia include aging populations, weakened immune systems, respiratory infections, air pollution, smoking, and the rise of antibiotic-resistant bacteria. Pulmonary or respiratory drug delivery helps treat pneumonia by directly delivering medications such as antibiotics, bronchodilators, or anti-inflammatory agents to the lungs, enabling quicker and more effective treatment to alleviate symptoms, reduce inflammation, clear infections, and improve respiratory function, thus aiding recovery and preventing complications. For example, in November 2023, the Centre for Tropical Medicine and Global Health reported a significant rise in pneumonia cases in Kenya, reaching 793,864 in the 2022/2023 period. As such, the increasing prevalence of pneumonia is driving the pulmonary or respiratory drug delivery market's growth.
Companies in the pulmonary or respiratory drug delivery market are focusing on innovations such as complex drug delivery systems that improve treatment efficacy and patient compliance. Complex drug delivery systems are advanced technologies that enhance the targeted delivery and controlled release of therapeutic agents, boosting drug effectiveness and patient outcomes. For example, in July 2023, Viatris Inc., a US-based healthcare company, and Kindeva Drug Delivery L.P., a US-based company specializing in drug delivery, launched Breyna (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol. Approved by the US Food and Drug Administration, this is the first generic version of AstraZeneca's Symbicort and combines budesonide and formoterol in a metered-dose inhaler for treating asthma and chronic obstructive pulmonary disease. It is available in two strengths, 80 micrograms and 160 micrograms, with 4.5 micrograms of formoterol.
In June 2022, Kindeva Drug Delivery acquired iPharma Labs Inc. for an undisclosed amount. This acquisition enhances Kindeva's capabilities in inhalation therapy development, allowing for improved formulation and manufacturing processes for respiratory medications. It also enables the company to offer comprehensive support to pharmaceutical clients from early-stage development to commercial production. iPharma Labs Inc. is a US-based company that specializes in pulmonary or respiratory drug delivery solutions.
Major players in the pulmonary or respiratory drug delivery market are Merck & Co. Inc., Novartis AG, Thermo Fisher Scientific Inc., AstraZeneca plc, Abbott Laboratories, 3M Company, Koninklijke Philips N.V., GlaxoSmithKline, Omron Corporation, Teva Pharmaceutical Industries Ltd., Aptar Pharma, Sumitomo Pharma America Inc., Chiesi Farmaceutici S.p.A., Cipla Inc., Boehringer Ingelheim GmbH, Kindeva Drug Delivery Limited, Nemera Group, Hovione, H And T Presspart Group, Vectura Group plc
North America was the largest region in the pulmonary or respiratory drug delivery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pulmonary or respiratory drug delivery report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the pulmonary or respiratory drug delivery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The pulmonary or respiratory drug delivery market consists of sales of metered-dose inhalers (MDIs), dry powder inhalers (DPIs), nebulizers, aerosol formulations, and smart inhalers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Pulmonary Or Respiratory Drug Delivery Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on pulmonary or respiratory drug delivery market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for pulmonary or respiratory drug delivery ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pulmonary or respiratory drug delivery market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product: Formulation Type, Device Type
2) By Canister Type: Plain Canister, Coated Canister
3) By Application: Chronic Obstructive Pulmonary Disease, Asthma, Cystic Fibrosis, Other Applications
4) By End-User: Hospitals, Clinics, Home Care Settings
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Pulmonary Or Respiratory Drug Delivery Market Characteristics
3. Pulmonary Or Respiratory Drug Delivery Market Trends And Strategies
4. Pulmonary Or Respiratory Drug Delivery Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Pulmonary Or Respiratory Drug Delivery Growth Analysis And Strategic Analysis Framework
5.1. Global Pulmonary Or Respiratory Drug Delivery PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Pulmonary Or Respiratory Drug Delivery Market Growth Rate Analysis
5.4. Global Pulmonary Or Respiratory Drug Delivery Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Pulmonary Or Respiratory Drug Delivery Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Pulmonary Or Respiratory Drug Delivery Total Addressable Market (TAM)
6. Pulmonary Or Respiratory Drug Delivery Market Segmentation
6.1. Global Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Formulation Type
Device Type
6.2. Global Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Plain Canister
Coated Canister
6.3. Global Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Chronic Obstructive Pulmonary Disease
Asthma
Cystic Fibrosis
Other Applications
6.4. Global Pulmonary Or Respiratory Drug Delivery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
Home Care Settings
6.5. Global Pulmonary Or Respiratory Drug Delivery Market, Sub-Segmentation Of Formulation Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Dry Powder Inhalers (DPIs)
Metered Dose Inhalers (MDIs)
Nebulizers
Liquid Aerosols
Nasal Sprays
6.6. Global Pulmonary Or Respiratory Drug Delivery Market, Sub-Segmentation Of Device Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Inhalers (Manual and Digital)
Nebulizers (Compressor, Ultrasonic, Mesh)
Breath-Activated Devices
Spacer Devices
Nasal Drug Delivery Devices
7. Pulmonary Or Respiratory Drug Delivery Market Regional And Country Analysis
7.1. Global Pulmonary Or Respiratory Drug Delivery Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Pulmonary Or Respiratory Drug Delivery Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Pulmonary Or Respiratory Drug Delivery Market
8.1. Asia-Pacific Pulmonary Or Respiratory Drug Delivery Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Pulmonary Or Respiratory Drug Delivery Market
9.1. China Pulmonary Or Respiratory Drug Delivery Market Overview
9.2. China Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Pulmonary Or Respiratory Drug Delivery Market
10.1. India Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Pulmonary Or Respiratory Drug Delivery Market
11.1. Japan Pulmonary Or Respiratory Drug Delivery Market Overview
11.2. Japan Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Pulmonary Or Respiratory Drug Delivery Market
12.1. Australia Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Pulmonary Or Respiratory Drug Delivery Market
13.1. Indonesia Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Pulmonary Or Respiratory Drug Delivery Market
14.1. South Korea Pulmonary Or Respiratory Drug Delivery Market Overview
14.2. South Korea Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Pulmonary Or Respiratory Drug Delivery Market
15.1. Western Europe Pulmonary Or Respiratory Drug Delivery Market Overview
15.2. Western Europe Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Pulmonary Or Respiratory Drug Delivery Market
16.1. UK Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Pulmonary Or Respiratory Drug Delivery Market
17.1. Germany Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Pulmonary Or Respiratory Drug Delivery Market
18.1. France Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Pulmonary Or Respiratory Drug Delivery Market
19.1. Italy Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Pulmonary Or Respiratory Drug Delivery Market
20.1. Spain Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Pulmonary Or Respiratory Drug Delivery Market
21.1. Eastern Europe Pulmonary Or Respiratory Drug Delivery Market Overview
21.2. Eastern Europe Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Pulmonary Or Respiratory Drug Delivery Market
22.1. Russia Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Pulmonary Or Respiratory Drug Delivery Market
23.1. North America Pulmonary Or Respiratory Drug Delivery Market Overview
23.2. North America Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Pulmonary Or Respiratory Drug Delivery Market
24.1. USA Pulmonary Or Respiratory Drug Delivery Market Overview
24.2. USA Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Pulmonary Or Respiratory Drug Delivery Market
25.1. Canada Pulmonary Or Respiratory Drug Delivery Market Overview
25.2. Canada Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Pulmonary Or Respiratory Drug Delivery Market
26.1. South America Pulmonary Or Respiratory Drug Delivery Market Overview
26.2. South America Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Pulmonary Or Respiratory Drug Delivery Market
27.1. Brazil Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Pulmonary Or Respiratory Drug Delivery Market
28.1. Middle East Pulmonary Or Respiratory Drug Delivery Market Overview
28.2. Middle East Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Pulmonary Or Respiratory Drug Delivery Market
29.1. Africa Pulmonary Or Respiratory Drug Delivery Market Overview
29.2. Africa Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Pulmonary Or Respiratory Drug Delivery Market Competitive Landscape And Company Profiles
30.1. Pulmonary Or Respiratory Drug Delivery Market Competitive Landscape
30.2. Pulmonary Or Respiratory Drug Delivery Market Company Profiles
30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.4. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
31. Pulmonary Or Respiratory Drug Delivery Market Other Major And Innovative Companies
31.1. 3M Company
31.2. Koninklijke Philips N.V.
31.3. GlaxoSmithKline
31.4. Omron Corporation
31.5. Teva Pharmaceutical Industries Ltd.
31.6. Aptar Pharma
31.7. Sumitomo Pharma America Inc.
31.8. Chiesi Farmaceutici S.p.A.
31.9. Cipla Inc.
31.10. Boehringer Ingelheim GmbH
31.11. Kindeva Drug Delivery Limited
31.12. Nemera Group
31.13. Hovione
31.14. H And T Presspart Group
31.15. Vectura Group plc
32. Global Pulmonary Or Respiratory Drug Delivery Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Pulmonary Or Respiratory Drug Delivery Market
34. Recent Developments In The Pulmonary Or Respiratory Drug Delivery Market
35. Pulmonary Or Respiratory Drug Delivery Market High Potential Countries, Segments and Strategies
35.1 Pulmonary Or Respiratory Drug Delivery Market In 2029 - Countries Offering Most New Opportunities
35.2 Pulmonary Or Respiratory Drug Delivery Market In 2029 - Segments Offering Most New Opportunities
35.3 Pulmonary Or Respiratory Drug Delivery Market In 2029 - Growth Strategies
